Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net sales	$ 391	$ 371	$ 1,208	$ 918
Cost of sales	(326)	(317)	(1,025)	(808)
Gross profit	65	54	183	110
Selling, general and administrative expenses	(38)	(43)	(118)	(124)
Research, development and engineering expenses, net	(102)	(124)	(326)	(299)
Amortization of intangibles	(2)	(1)	(6)	(4)
Other (expense)/ income, net	(12)	11	(18)	27
Operating loss	(89)	(103)	(285)	(290)
Loss on divestiture and assets impairment charge, net	0	(24)	0	(91)
Gain (loss) from equity method investment	3	(1)	12	(39)
Interest income	1	1	2	8
Interest expense	(5)	(5)	(16)	(15)
Other non-operating items, net	(1)	0	1	0
Loss before income taxes	(91)	(132)	(286)	(427)
Income tax expense	(3)	0	(12)	(26)
Net loss	(94)	(132)	(298)	(453)
Less: Net income attributable to non-controlling interest	0	0	0	1
Net loss attributable to controlling interest	$ (94)	$ (132)	$ (298)	$ (454)
Net loss per share - basic (in dollars per share)	$ (0.84)	$ (1.18)	$ (2.66)	$ (4.07)
Net loss per share - diluted (in dollars per share)	$ (0.84)	$ (1.18)	$ (2.66)	$ (4.07)
Weighted average number of shares outstanding (in millions)	111,960	111,590	111,830	111,550
Weighted average number of shares outstanding, assuming dilution (in millions)	111,960	111,590	111,830	111,550